COMP <GO>
RNXT vs CPIX // EV/EBITDA & P/E VALUATION
RenovoRx Inc. (NASDAQ) VS. Cumberland Pharmaceuticals Inc. (NASDAQ) • 15-METRIC TALLY: RNXT 3
— CPIX 7
■ METRIC PARITY
LAST: $1.33 (-10.74%) • MKT CAP: $67.2M
valuation
—
LAST: $4.69 (+7.82%) • MKT CAP: $65.2M
valuation
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (RNXT VS. CPIX)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | RNXT | CPIX | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 70.90% | 85.00% | -14.10 | CPIX | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | -16.40% | -18.60 | CPIX | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -16.32% | 7.42% | -23.74 | CPIX | /fcf-yield <GO> |
| Operating Margin | -60.00% | -6.30% | -53.70 | CPIX | /operating-margins <GO> |
| Net Profit Margin | -60.00% | -6.40% | -53.60 | CPIX | /net-margins <GO> |
| Revenue Growth (YoY) | 180.00% | 17.60% | +162.40 | RNXT | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.40 | 0.72 | -0.32 | CPIX | /balance-sheet <GO> |
| Piotroski F-Score Quality | 4/9 | 7/9 | -3.00 | CPIX | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 47.1 | 35.3 | +11.87 | RNXT | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $67.2M | $65.2M | $2.1M | RNXT | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | RNXT REV | CPIX REV | RNXT GROSS % | CPIX GROSS % | RNXT FCF | CPIX FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $1.1M | $44.5M | 70.9% | 85.0% | -$11.0M | $4.8M |
| FY 2024 | $43.0K | $37.9M | 98.0% | 82.6% | -$9.1M | -$678.6K |
| FY 2023 | $0 | $39.6M | — | — | -$10.3M | $6.1M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
RNXT // BETA —
CPIX // BETA —